Provided by Tiger Trade Technology Pte. Ltd.

SELLAS Life Sciences Group Inc.

12.31
+0.80006.95%
Post-market: 12.360.0492+0.40%19:59 EDT
Volume:8.62M
Turnover:104.53M
Market Cap:2.49B
PE:-57.98
High:12.53
Open:11.51
Low:11.20
Close:11.51
52wk High:15.88
52wk Low:1.39
Shares:201.95M
Float Shares:199.00M
Volume Ratio:2.15
T/O Rate:4.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2123
EPS(LYR):-0.2463
ROE:-39.63%
ROA:-23.30%
PB:18.06
PE(LYR):-49.97

Loading ...

Earnings Flash (SLS) SELLAS Life Sciences Posts Q2 Loss $0.05, vs. FactSet Est of $0.05 Loss

MT Newswires Live
·
Aug 12

SELLAS Life Sciences Gr Q2 EPS $(0.05) Misses $(0.04) Estimate

Benzinga Earnings
·
Aug 12

Sellas Life Sciences Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 12

Sellas Life Sciences Q2 Basic EPS USD -0.05

THOMSON REUTERS
·
Aug 12

Sellas Life Sciences Q2 Net Income USD -9.605 Million

THOMSON REUTERS
·
Aug 12

Press Release: Sellas Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 12

Sellas Net Loss Widens 45,51% to $ 9,61 Juta in Q2 FY26

Reuters
·
Aug 12

Canaccord Genuity Keeps Their Buy Rating on Solstice Minerals Limited (SLS)

TIPRANKS
·
Aug 04

Moderately bullish activity in Sellas Life Sciences with shares up 7.39%

TIPRANKS
·
Aug 03

Cboe data shows mixed options sentiment in Sellas Life Sciences with shares down 3.3%

TIPRANKS
·
Aug 01

Movement Alert|SELLAS Life Sciences Group Inc. Falls 8.63% in Regular Trading, All Arbitration Claims Dismissed

Market Focus
·
Jul 28

Moderately bullish activity in Sellas Life Sciences with shares down 11.17%

TIPRANKS
·
Jul 28

Sellas Life Sciences Group - Company to Pay About $1 Mln of 3D Medicines' Legal Fees - SEC Filing

THOMSON REUTERS
·
Jul 28

Sellas Life Sciences Group Inc: 3D Medicines Will Continue Development & Commercialization of Galinpepimut-S in Greater China Territory

THOMSON REUTERS
·
Jul 28

Sellas Arbitration Claim Against 3D Medicines Dismissed, Owes $1 Million in Legal Fees

Reuters
·
Jul 28

Movement Alert|SELLAS Life Sciences Group Inc. Falls 14.89% in Regular Trading, All Arbitration Claims Dismissed in Hong Kong Case

Market Focus
·
Jul 28

Movement Alert|SELLAS Life Sciences Group Inc. Falls 8.35% in Regular Trading, Trading at $11.29

Market Focus
·
Jul 25

Movement Alert|SELLAS Life Sciences Group Inc. Falls 8.06% in Regular Trading, Trading at $11.89

Market Focus
·
Jul 23

Movement Alert|SELLAS Life Sciences Falls 8.85% in Regular Trading, Trading at $12.075

Market Focus
·
Jul 20

SELLAS Life Sciences Group (SLS) Stock Trades At A Premium On Book Value Despite A 7x Return

Simply Wall St.
·
Jul 19